Sexual dysfunction after radical prostatectomy: treatment failure or treatment delay?

Area of Science:

• Urology
• Sexual Medicine
• Men's Health

Background:

• Erectile dysfunction (ED) is a common complication following radical retropubic prostatectomy (RRP).
• Phosphodiesterase-5 inhibitors (PDE5I) are a first-line treatment, but many men do not achieve satisfactory results.
• Delayed help-seeking for second-line ED treatments is a significant clinical challenge.

Purpose of the Study:

• To define characteristics of delayed help-seeking in men with post-RRP ED who failed PDE5I treatment.
• To analyze patterns of seeking and adhering to second-line ED therapies.

Main Methods:

• Retrospective review of medical charts for 31 patients who failed PDE5I treatment post-RRP.
• Analysis of help-seeking duration and uptake of second-line treatments: intracavernous injection (ICI), vacuum devices, and sex therapy.

Main Results:

• The average delay for second-line help-seeking was 25.9 months post-RRP.
• Despite failing PDE5I, 35% of patients declined treatment, expecting spontaneous recovery.
• Intracavernous injection (ICI) was the most common second-line treatment (65%); 25% of ICI users regained spontaneous erections, and 35% responded to PDE5I after starting ICI.
• Sex therapy with a partner improved sexual life for all participants who engaged.

Conclusions:

• Misconceptions about spontaneous recovery contribute to delayed treatment seeking.
• Comprehensive patient education on sexual recovery post-RRP is essential to encourage early intervention.
• Second-line treatments like ICI and adjunct sex therapy can be effective for managing persistent ED.